Partner Harvey Kesner Represents MabVax Therapeutics Holdings, Inc. in a Debt Facility for up to $10,000,000
Press Release – New York, NY – January 21, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented MabVax Therapeutics Holdings, Inc. in connection with a debt facility for up to $10,000,000 of which the Company has received $5,000,000. The company focuses on developing vaccine antibody-based therapeutics for the diagnosis and treatment of cancer. The Sichenzia Ross Friedman Ference LLP team was led by Harvey Kesner, David Manno and Tara Guarneri-Ferrara.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner Associate Cass Sanford Quoted in Business Insider Article on Topics Surrounding Reg A+ - May 12, 2017
- Sichenzia Ross Ference Kesner LLP Celebrates its 19th Anniversary - May 9, 2017
- Sichenzia Ross Ference Kesner LLP Advises PolarityTE, Inc. on Acquisition of Intellectual Property Related to Regenerative Medicine - May 7, 2017